Literature DB >> 17334389

Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.

S Rodrigues1, O De Wever, E Bruyneel, R J Rooney, C Gespach.   

Abstract

Deleted in colon cancer (DCC) and UNC5 function as netrin dependence receptors by inducing apoptosis in the absence of their ligand and accordingly were recently designated as putative conditional tumor suppressors. Herein, we determined whether netrin-1 and its receptors are implicated in cancer cell invasion and tumor progression. Expression of DCC, UNC5 and adenosine A2B-receptors (A2B-Rs) was investigated by reverse transcription polymerase chain reaction in human colon cancer cells. The impact of DCC restitution and netrin-1 was evaluated on collagen type I invasion, tumor growth and metastasis in nude mice, cancer cell survival and gene expression profiling. Flow cytometry, poly(ADP-ribose)polymerase-1 and caspase-8 activation were used to evaluate the impact of DCC on cell death. Both netrin-1 and A2B-R activation induced the invasive phenotype through the Rho-Rho kinase axis in DCC-deficient human colorectal cancer cells. Restitution of wild-type DCC blocked invasion induced by netrin-1, A2B-R agonist and other agents. Ectopic expression of netrin-1 led to increased growth of human colon tumor xenografts in athymic mice. Conversely, introduction of wt-DCC in kidney MDCKts.src-ggl cells strongly inhibited metastasis in lymph nodes and lungs and increased sensitivity to apoptosis in hypoxia. DNA microarrays revealed that netrin and DCC had common and divergent impacts on gene expression linked to cell cycle, survival, surface signaling and adhesion. Our findings underscore that netrin is a potent invasion and tumor growth-promoting agent and that DCC is a metastasis suppressor gene targeting both proinvasive and survival pathways in a cumulative manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334389     DOI: 10.1038/sj.onc.1210347

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  Rb/E2F regulates expression of neogenin during neuronal migration.

Authors:  Matthew G Andrusiak; Kelly A McClellan; Delphie Dugal-Tessier; Lisa M Julian; Sonia P Rodrigues; David S Park; Timothy E Kennedy; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2010-11-08       Impact factor: 4.272

2.  An adenosine-mediated signaling pathway suppresses prenylation of the GTPase Rap1B and promotes cell scattering.

Authors:  Elizabeth Ntantie; Patrick Gonyo; Ellen L Lorimer; Andrew D Hauser; Nathan Schuld; Donna McAllister; Balaraman Kalyanaraman; Michael B Dwinell; John A Auchampach; Carol L Williams
Journal:  Sci Signal       Date:  2013-05-28       Impact factor: 8.192

Review 3.  The role of UNC5C in Alzheimer's disease.

Authors:  Quan Li; Bai-Ling Wang; Fu-Rong Sun; Jie-Qiong Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 4.  Adenosine receptors in wound healing, fibrosis and angiogenesis.

Authors:  Igor Feoktistov; Italo Biaggioni; Bruce N Cronstein
Journal:  Handb Exp Pharmacol       Date:  2009

5.  Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability.

Authors:  Qi Qi; Dean Y Li; Hongbo R Luo; Kun-Liang Guan; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

6.  The Drosophila Netrin receptor frazzled/DCC functions as an invasive tumor suppressor.

Authors:  Adrienne VanZomeren-Dohm; Joseph Sarro; Ellen Flannery; Molly Duman-Scheel
Journal:  BMC Dev Biol       Date:  2011-06-14       Impact factor: 1.978

7.  Netrin-1 specifically enhances cell spreading on fibronectin in human glioblastoma cells.

Authors:  Hyun Kyoung Lee; In Ae Seo; Yoon Kyung Shin; Sang Hwa Lee; Su-Young Seo; Duk Joon Suh; Hwan Tae Park
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

Review 8.  Netrin and DCC: axon guidance regulators at the intersection of nervous system development and cancer.

Authors:  M Duman-Scheel
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

9.  Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells.

Authors:  Liu Meimei; Li Peiling; Li Baoxin; Li Changmin; Zhuang Rujin; Hu Chunjie
Journal:  Med Oncol       Date:  2010-01-07       Impact factor: 3.064

Review 10.  Soluble cadherins as cancer biomarkers.

Authors:  Olivier De Wever; Lara Derycke; An Hendrix; Gert De Meerleer; François Godeau; Herman Depypere; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.